A hormone called GDF15 triggers a part of the brain involved in nausea and vomiting, a new study finds. Blocking its action may lead to treatments.
Ozempic and related drugs can drastically reduce body weight, and more potent versions are on the way. But questions remain about who should take them.
In a trial of 10 people with familial hypercholesterolemia, a genetic medicine reduced levels of LDL cholesterol in the blood by up to 55 percent.
In the world’s first CRISPR-based treatment, genetic tweaks to red blood cells aim to help people with the often debilitating disease.
After deep brain stimulation, five patients with severe brain injuries improved their scores on a test of cognitive function.
The automated device pairing brain activity and dosing kept two macaques sedated for 125 minutes, raising hopes of precision anesthesia for people.
Cells responsible for humans’ sense of smell can regenerate. Now, research spurred on by the pandemic could help answer questions about the process.
A genetic variant commonly found in certain African populations appears to impair tamoxifen’s ability to tackle breast cancer.
The water crisis started almost a decade ago. Residents of Flint, Mich., are still healing from the disaster — and caring for their own.
Among 17,000 adults, those on semaglutide were less likely to experience nonfatal heart attacks and strokes or death due to cardiovascular disease.
